- Home
- AIMD vs FRES Comparison
AIMD vs FRES Comparison
Compare AIMD & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- FRES
- Stock Information
- Founded
- AIMD 1984
- FRES 2010
- Country
- AIMD United States
- FRES United States
- Employees
- AIMD N/A
- FRES N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- FRES Medical Specialities
- Sector
- AIMD Health Care
- FRES Health Care
- Exchange
- AIMD Nasdaq
- FRES Nasdaq
- Market Cap
- AIMD 5.2M
- FRES 6.4M
- IPO Year
- AIMD N/A
- FRES 2020
- Fundamental
- Price
- AIMD $0.55
- FRES $1.85
- Analyst Decision
- AIMD
- FRES
- Analyst Count
- AIMD 0
- FRES 0
- Target Price
- AIMD N/A
- FRES N/A
- AVG Volume (30 Days)
- AIMD 1.2M
- FRES 4.8K
- Earning Date
- AIMD 08-05-2024
- FRES 09-17-2024
- Dividend Yield
- AIMD N/A
- FRES N/A
- EPS Growth
- AIMD N/A
- FRES N/A
- EPS
- AIMD N/A
- FRES N/A
- Revenue
- AIMD $65,122.00
- FRES $2,341,326.00
- Revenue This Year
- AIMD N/A
- FRES N/A
- Revenue Next Year
- AIMD N/A
- FRES N/A
- P/E Ratio
- AIMD N/A
- FRES N/A
- Revenue Growth
- AIMD N/A
- FRES 94.50
- 52 Week Low
- AIMD $0.48
- FRES $1.55
- 52 Week High
- AIMD $4.32
- FRES $26.00
- Technical
- Relative Strength Index (RSI)
- AIMD 35.01
- FRES 43.57
- Support Level
- AIMD $0.61
- FRES $1.58
- Resistance Level
- AIMD $0.67
- FRES $2.01
- Average True Range (ATR)
- AIMD 0.05
- FRES 0.17
- MACD
- AIMD -0.00
- FRES 0.05
- Stochastic Oscillator
- AIMD 9.24
- FRES 62.50
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About FRES Fresh2 Group Limited
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.